Spectral Medical Inc EDT-CA:Toronto Stock Exchange

*Data is delayed | CAD
Last | 3:56 PM EDT
0.40quote price arrow down-0.005 (-1.23%)
Volume
56,601
52 week range
0.15 - 0.62
Loading...
  • Open0.41
  • Day High0.41
  • Day Low0.40
  • Prev Close0.405
  • 52 Week High0.62
  • 52 Week High Date06/16/22
  • 52 Week Low0.15
  • 52 Week Low Date11/19/21

Key Stats

  • Market Cap96.37M
  • Shares Out268.15M
  • 10 Day Average Volume97,157.91
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change81.82

KEY STATS

  • Open0.41
  • Day High0.41
  • Day Low0.40
  • Prev Close0.405
  • 52 Week High0.62
  • 52 Week High Date06/16/22
  • 52 Week Low0.15
  • 52 Week Low Date11/19/21
  • Market Cap96.37M
  • Shares Out268.15M
  • 10 Day Average Volume97,157.91
  • Dividend-
  • Dividend Yield-
  • Beta1.43
  • YTD % Change81.82

RATIOS/PROFITABILITY

  • EPS (TTM)-0.04
  • P/E (TTM)-10.58
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Spectral Medical Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Spectral Medical Inc. is a late stage theranostic company that is focused on advancing therapeutic options for sepsis and septic shock. The Company has conducted a Phase III clinical trial for its lead product, PMX (Toraymyxin PMX-20R), which is for the treatment of patients with septic shock and endotoxemia that is measured by the Company’s Endotoxin Activity Assay (EAA). EAA and PMX are both Health Canada licensed and commercially available in Canada. The Company through...
Anthony Bihl III
Non-Executive Independent Chairman of the Board
Chris Seto
Chief Executive Officer
Paul Walker M.D., Ph.D.
President, Director
Blair Mcinnis
Chief Financial Officer
Address
135 - 2 The West Mall
Toronto, ON
M9C 1C2
Canada